Identifying these factors can help open the door to treatment and prevention options. Multiple sclerosis (MS) is a disease of the central nervous system. More than 2.8 million people worldwide ...

The treatment of multiple sclerosis (MS) has improved dramatically over the past two decades thanks to the advent of a second generation of immunomodulatory therapies. They have significantly ...

Different people can have different types of MS, and disease progression and symptoms range greatly from person to person. For both reasons, each person’s treatment plan will be different.

Researchers have made more advancements in multiple sclerosis in the last five years than in the previous 70 years. Knowing ...

New Study Finds a Promising Combined Therapy for Multiple Sclerosis Oct. 2, 2024 — Researchers have found a potential new way to improve the treatment of multiple sclerosis (MS) using a novel ...

Mothers with multiple sclerosis had an elevated incidence and prevalence of peripartum mental illness vs. mothers without MS ...

The FDA issued a boxed warning for anaphylaxis risk linked to Glatiramer acetate and Glatopa, used in MS treatment.

Overall, women with MS have a 26% increased risk of mental illness during pregnancy and a 33% increased risk after giving ...

Two key symptoms that can arise soon after a diagnosis of multiple sclerosis (MS) could predict how swiftly the illness will progress and suggest best treatment options, new research shows.

James Evans MS is proud to be supporting the upcoming ‘Stroke Prevention Day’ on Thursday, January 30. The Stroke Association ...

Pick the best stocks and maximize your portfolio: BioNxt Solutions has made significant progress in developing BNT23001, a new treatment for Multiple Sclerosis, achieving key milestones in 2024.